FI890779A - 14,17 -etano-14 -estratrieenejä, menetelmä niiden valmistamiseksi ja niitä sisältäviä, ehkäisyaineina käytettäviä valmisteita - Google Patents

14,17 -etano-14 -estratrieenejä, menetelmä niiden valmistamiseksi ja niitä sisältäviä, ehkäisyaineina käytettäviä valmisteita Download PDF

Info

Publication number
FI890779A
FI890779A FI890779A FI890779A FI890779A FI 890779 A FI890779 A FI 890779A FI 890779 A FI890779 A FI 890779A FI 890779 A FI890779 A FI 890779A FI 890779 A FI890779 A FI 890779A
Authority
FI
Finland
Prior art keywords
ethano
estratrienes
contraceptives
preparation
hydrogen atom
Prior art date
Application number
FI890779A
Other languages
English (en)
Swedish (sv)
Other versions
FI94866C (fi
FI890779A0 (fi
FI94866B (fi
Inventor
James R Bull
Russel I Thomson
Henry Laurent
Helmut Schroeder
Rudolf Wiechert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI890779A0 publication Critical patent/FI890779A0/fi
Publication of FI890779A publication Critical patent/FI890779A/fi
Application granted granted Critical
Publication of FI94866B publication Critical patent/FI94866B/fi
Publication of FI94866C publication Critical patent/FI94866C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI890779A 1986-08-20 1989-02-17 14,17 -etano-14 -estratrieenejä, menetelmä niiden valmistamiseksi ja niitä sisältäviä, ehkäisyaineina käytettäviä valmisteita FI94866C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3628189 1986-08-20
DE19863628189 DE3628189A1 (de) 1986-08-20 1986-08-20 Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene
PCT/DE1987/000361 WO1988001275A1 (en) 1986-08-20 1987-08-11 14,17beta-ETHANO-14beta-ESTRATRIENES AND ESTRATETRAENES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
DE8700361 1987-08-11

Publications (4)

Publication Number Publication Date
FI890779A0 FI890779A0 (fi) 1989-02-17
FI890779A true FI890779A (fi) 1989-02-17
FI94866B FI94866B (fi) 1995-07-31
FI94866C FI94866C (fi) 1995-11-10

Family

ID=6307762

Family Applications (1)

Application Number Title Priority Date Filing Date
FI890779A FI94866C (fi) 1986-08-20 1989-02-17 14,17 -etano-14 -estratrieenejä, menetelmä niiden valmistamiseksi ja niitä sisältäviä, ehkäisyaineina käytettäviä valmisteita

Country Status (22)

Country Link
US (1) US4789671A (fi)
EP (1) EP0318490B1 (fi)
JP (1) JPH02500739A (fi)
KR (1) KR940000167B1 (fi)
CN (1) CN1027270C (fi)
AT (1) ATE72248T1 (fi)
AU (1) AU618939B2 (fi)
CA (1) CA1269102A (fi)
DD (1) DD266801A5 (fi)
DE (2) DE3628189A1 (fi)
DK (1) DK186788D0 (fi)
FI (1) FI94866C (fi)
HU (1) HU203366B (fi)
IE (1) IE60319B1 (fi)
IL (1) IL83302A (fi)
NO (2) NO167865C (fi)
NZ (1) NZ221137A (fi)
PT (1) PT85552B (fi)
RU (1) RU1820910C (fi)
UA (1) UA13378A (fi)
WO (1) WO1988001275A1 (fi)
ZA (1) ZA875359B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3838779A1 (de) * 1988-11-11 1990-05-17 Schering Ag 14(alpha),17(alpha)-ethano-estratriene
DE3925507A1 (de) * 1989-07-28 1991-01-31 Schering Ag 14,17(alpha)-etheno- und ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
RU2087479C1 (ru) * 1989-11-29 1997-08-20 Шеринг Аг Эстратриены, содержащие мостик
DE4114634A1 (de) * 1991-04-30 1992-11-05 Schering Ag 14(alpha),17(alpha)-(propano- und 17(pfeil hoch)2(pfeil hoch)-propeno)estratriene
DE4114635A1 (de) * 1991-04-30 1992-11-05 Schering Ag 14(alpha),16(alpha)-ethano-estratriene
DE4222316A1 (de) * 1992-07-03 1994-01-05 Schering Ag Verfahren zur Herstellung von Etheno- und Ethano-16â,17µ-Steroiddiolen und deren Derivaten
DE4326240A1 (de) * 1993-08-02 1995-02-09 Schering Ag 15,15-Dialkyl-substituierte Derivate des Estradiols
DE4447401A1 (de) 1994-12-23 1996-07-04 Schering Ag 14,17-C¶2¶-überbrückte Steroide
US7435757B2 (en) * 2004-07-02 2008-10-14 Schering Ag 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1

Also Published As

Publication number Publication date
AU618939B2 (en) 1992-01-16
PT85552A (en) 1987-09-01
EP0318490B1 (de) 1992-01-29
NO885112D0 (no) 1988-11-16
NO167865B (no) 1991-09-09
FI94866C (fi) 1995-11-10
FI890779A0 (fi) 1989-02-17
CN1027270C (zh) 1995-01-04
WO1988001275A1 (en) 1988-02-25
NZ221137A (en) 1990-09-26
NO881688D0 (no) 1988-04-19
NO168481C (no) 1992-04-01
EP0318490A1 (de) 1989-06-07
JPH02500739A (ja) 1990-03-15
US4789671A (en) 1988-12-06
DE3776572D1 (de) 1992-03-12
HU203366B (en) 1991-07-29
DK186788A (da) 1988-04-06
FI94866B (fi) 1995-07-31
PT85552B (pt) 1990-05-31
KR880701731A (ko) 1988-11-04
CA1269102A (en) 1990-05-15
NO885112L (no) 1988-04-19
NO167865C (no) 1991-12-18
DD266801A5 (de) 1989-04-12
UA13378A (uk) 1997-02-28
HUT50845A (en) 1990-03-28
DK186788D0 (da) 1988-04-06
IE60319B1 (en) 1994-06-29
IE872217L (en) 1988-02-20
ZA875359B (en) 1988-02-05
KR940000167B1 (ko) 1994-01-08
CN87105736A (zh) 1988-03-09
AU7757187A (en) 1988-03-08
ATE72248T1 (de) 1992-02-15
DE3628189A1 (de) 1988-02-25
IL83302A (en) 1991-09-16
IL83302A0 (en) 1987-12-31
JPH0515720B2 (fi) 1993-03-02
NO168481B (no) 1991-11-18
RU1820910C (ru) 1993-06-07
NO881688L (no) 1988-04-19

Similar Documents

Publication Publication Date Title
GR82548B (en) Iib - aryl - estradien, preparation thereof, an pharmaceutical preparations containing said compound
ATE1814T1 (de) 9-hydroxyalkylpurine, verfahren zu ihrer herstellung und 9-hydroxyalkylpurine als aktive mittel enthaltende therapeutische zusammensetzung.
WO1988000042A1 (en) New 5-alkoxy-2,4-diamino-alkyl benzols, and hair tinting means using them
ES8401961A1 (es) Procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil-bencimidazolonas sustituidas.
NO850224L (no) Fremgangsmaate ved fremstilling av 6,6-ethylen-15,16-methylen-3-oxo-17alfa-pregn-4-en-21,17-carbolactoner
FI890779A (fi) 14,17 -etano-14 -estratrieenejä, menetelmä niiden valmistamiseksi ja niitä sisältäviä, ehkäisyaineina käytettäviä valmisteita
DE3762860D1 (de) 2-thiazolylimidazo(1,2-a)pyrimidine und ihre salze, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
ES8200108A1 (es) Un procedimiento para la preparacion de derivados de tioxan tina.
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
DE3468209D1 (en) P-oxybenzoic acid derivatives, methods for preparing them, and their use for the preparation of medicaments with hypolipemic activity
DE3261515D1 (en) Benzopyranyl ethers, process for their preparation and medicine containing those compounds and intermediates
ATE18228T1 (de) Neue thieno-thiazol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE18211T1 (de) Chinolinessigsaeuren und diese enthaltende pharmazeutische zubereitungen.
SE8303719D0 (sv) Novel eburnane oxime derivatives and process for preparing same
ES2071832T3 (es) Procedimiento para la preparacion de derivados de 21-bromo-4-pregneno-3,20-diona.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: SCHERING AKTIENGESELLSCHAFT